Study to Assess Droxidopa in the Treatment of Freezing Of Gait Symptoms in Patients With Parkinson's Disease

NCT01331122 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Never initiated. Withdrawn by sponsor.

Conditions

Gait Disorders, Neurologic

Interventions

DRUG: droxidopa

Sponsor

Chelsea Therapeutics